University of Illinois Hospital and Health Sciences System .

Chicago, Illinois 60612-7232

4 studies enrolling now · 24 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Anemia, Sickle Cell, Asthma, Breast Cancer, CPAP, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Covid19, Diabetes Mellitus, Type 2, Heart Failure, Hematologic Malignancy, Hepatocellular Carcinoma

Studies at this site

• A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) — Recruiting now
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations — Recruiting now
• Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Recruiting now
• A Phase 2/3 Study in Adult and Adolescent Participants With SCD — Recruiting now
• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma — Running, not enrolling
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) — Running, not enrolling
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• Sleep for Stroke Management and Recovery Trial — Running, not enrolling
• Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD — Stopped early
• EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer — Stopped early
• Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
• Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease — Completed
• mHealth for Diabetes Adherence Support — Completed
• Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients — Completed
• physicAl aCtiviTy In minOrity womeN With Asthma Intervention — Completed
• Detection of COVID-19 Decompensation — Completed
• Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure — Completed
• Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation — Stopped early
• Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain — Stopped early
• Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage — Stopped early
• Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease — Completed
• Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children — Completed
• Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia — Completed